Basic information about inhibitors

IPAD-DB ID	C00745
Name	8-Hydroxyquinolin-2-yl)methyl-4-(5-methoxy-1H-indole-2-carbonyl)piperazine-1-carboxylate (18d)
Category	Natural compounds
2D Structure
3D Structure
Molecular Formula	-
Molecular Weight	-
IUPAC Name	(8-hydroxyquinolin-2-yl)methyl 4-(5-methoxy-1H-indole-2-carbonyl)piperazine-1-carboxylate
InChI	InChI=1S/C25H24N4O5/c1-33-19-7-8-20-17(13-19)14-21(27-20)24(31)28-9-11-29(12-10-28)25(32)34-15-18-6-5-16-3-2-4-22(30)23(16)26-18/h2-8, 13-14, 27, 30H, 9-12, 15H2, 1H3
InChIKey	WAUUFPLRVYMBPX-UHFFFAOYSA-N
Canonical SMILES	OC1=C2C(C=CC(COC(N3CCN(C(C4=CC5=C(C=CC(OC)=C5)N4)=O)CC3)=O)=N2)=C([H])C=C1[H]
PubChem CID	-
DrugBank Accession Number	-
CAS Registry Number	-

Biological activity data

Ki	-
EC50	1.48 μM(Aβ1-42)
IC50	-
Inhibition	-
Toxicity	-
ROS(reactive oxygen species)	-
Metal Chelating	Cu2+, Zn2+
BBB(blood-brain barrier)	-
Target Protein	Aβ1-42
Effects	(1) Hybrid compound 18d afforded 66.1% and 59.3% inhibition, respectively, against Cu2+- induced and Zn2+- induced Aβ1–42 aggregation,
Research Models	SY5Y-APPSw cells, Molecular docking, In vitro
Main Source	-
Ref. Link

Physicochemical properties

Molecular Weight(Computed by SwissADME)	460.48
Hac(Computed by SwissADME)	34
Volume(Computed by ADMETlab 2.0)	457.111
Density(Computed by ADMETlab 2.0)	1.007
nRing(Computed by ADMETlab 2.0)	5
MaxRing(Computed by ADMETlab 2.0)	10
nHet(Computed by ADMETlab 2.0)	9
fChar(Computed by ADMETlab 2.0)	0
nRig(Computed by ADMETlab 2.0)	29
Flexibility(Computed by ADMETlab 2.0)	0.241
Stero Centers(Computed by ADMETlab 2.0)	0
LogS(Computed by ADMETlab 2.0)	-4.409
LogD(Computed by ADMETlab 2.0)	3.365

ADMET properties

logP(Computed by ADMETlab 2.0)	3.52
TPSA(Computed by SwissADME)	107.99 Ų
Hbond Acceptor(Computed by SwissADME)	6
Hbond Donor(Computed by SwissADME)	2
Rotatable Bonds(Computed by SwissADME)	7

Pharmacokinetics

GI Absorption(Computed by SwissADME)	High
BBB(blood-brain barrier) Permeant(Computed by SwissADME)	No
P-gp Substrate(Computed by SwissADME)	Yes
CYP1A2 Inhibitor(Computed by SwissADME)	No
CYP2C19 Inhibitor(Computed by SwissADME)	Yes
CYP2C9 Inhibitor(Computed by SwissADME)	Yes
CYP2D6 Inhibitor(Computed by SwissADME)	Yes
CYP3A4 Inhibitor(Computed by SwissADME)	Yes
log Kp(Skin Permeation)(Computed by SwissADME)	-7.03 cm/s

Druglikeness

Lipinski(Computed by SwissADME)	Yes, 0 violation
Ghose(Computed by SwissADME)	No, 1 violation: MR>130
Veber(Computed by SwissADME)	Yes
Egan(Computed by SwissADME)	Yes
Muegge(Computed by SwissADME)	Yes
Bioavailability Score(Computed by SwissADME)	0.55